A CCTA-based radiomics method was recently found to be more accurate in identifying potentially problematic plaques than conventional CCTA anatomical parameters alone.

Most FDA-cleared AI algorithms are related to radiology and cardiology, meaning radiologists and cardiologists need to make an effort to learn how these technologies work.

While the ACC/AHA 2021 Chest Pain Assessment Guidelines included cardiac CT angiography as a top level recommendation, gaps in evidence still need to be filled.

Not only does the low-volume contrast protocol preserve supplies, it also protects patients who might be vulnerable to adverse reactions and/or side effects from contrast use. 

Researchers examined data from nearly 2 million patients, sharing their full findings in JACC: Cardiovascular Imaging.

Primary aldosteronism (PA) is one the single most common causes of hypertension, but identifying patients with PA—and knowing which ones may benefit from a surgical treatment—can be quite challenging.

Researchers recently found results yielded via subtraction CCTA to be similar to those produced by ICA in assessing stenosis grading.

The FDA is reclassifying interventional cardiovascular implant simulation software into the class II (special controls) regulatory category, which will make it easier for the technology to pass regulatory approval.